Sec. 208. Authorization for United States participation in the Coalition for Epidemic Preparedness Innovations
370 words·~2 min read·
/bill/117/s/2297/rs/section-208A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
The United States is authorized to participate in the Coalition for Epidemic Preparedness Innovations (referred to in this section as CEPI ). The President shall designate an employee of the United States Agency for International Development to serve on the Investors Council and, if nominated, on the Board of Directors of CEPI, as a representative of the United States during the period beginning on the date of such designation and ending on September 30, 2022. The President may designate an employee of the relevant Federal department or agency with fiduciary responsibility for United States contributions to CEPI to serve on the Investors Council and, if nominated, on the Board of Directors of CEPI, as a representative of the United States.
Any employee designated pursuant to paragraph
(1)or
(2)shall have demonstrated knowledge and experience in the fields of development and public health, epidemiology, or medicine, from the Federal department or agency with primary fiduciary responsibility for United States contributions pursuant to subsection (c). Not later than 60 days after the date of the enactment of this Act, the employee designated pursuant to subsection (b)(1) shall consult with the appropriate congressional committees regarding— the manner and extent to which the United States plans to participate in CEPI, including through the governance of CEPI; any planned financial contributions from the United States to CEPI; and how participation in CEPI is expected to support— the United States Global Health Security Strategy required under this Act; the applicable revision of the National Biodefense Strategy required under section 1086 of the National Defense Authorization Act for Fiscal Year 2017 ( 6 U.S.C. 104 ); and any other relevant programs relating to global health security and biodefense. It is the sense of Congress that the President, consistent with the provisions under section 10003(a)(1) of the American Rescue Plan Act of 2021 , should make an immediate contribution to CEPI in the amount of $300,000,000, to expand research and development of vaccines to combat the spread of COVID–19 variants. Not later than 15 days before a contribution is made available pursuant to paragraph (1), the President shall notify the appropriate congressional committees of the details of the amount, purposes, and national interests served by such contribution.
Connectionstraces to 1
Traces to 1 document
U.S. Code
Citation graph
cites case law
Sec. 208
Authorization for United States participation in the Coalition for Epidemic Preparedness Innovations
Cites 1Cited by 0 across 0 sources